Check Before You Invest : Biopol Chemicals Ltd

Q: Which industry/sub-sector does Biopol Chemicals Ltd belong to?

Biopol Chemicals Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.

Q: Is Biopol Chemicals Ltd a good quality company?

Biopol Chemicals Ltd is a weak quality company, based on a inconsistent multi-year financial track record. This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

Q: Is Biopol Chemicals Ltd undervalued or overvalued?

Biopol Chemicals Ltd appears Undervalued, as its key valuation ratios are lower than their past averages. Based on the industry it operates in, the relevant valuation ratios include one of the following, P/E, P/BV, P/Sales, EV/EBITDA or a combination of two or more. Valuation Ratios. Price to Earnings, Current: 14.63, Historic Median: 20.55. Price to Book, Current: 2.63, Historic Median: 2.04. Price to Sales, Current: 1.62, Historic Median: 1.57. EV to EBITDA, Current: 10.08, Historic Median: 14.58

Q: Is Biopol Chemicals Ltd a good buy now?

Biopol Chemicals Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Q: Debt to Equity ratio of Biopol Chemicals Ltd?

Biopol Chemicals Ltd Debt-to-Equity ratio is 0.57, which is above the industry average of , indicating higher debt levels in the industry.

Q: Debt to cash flow from operations of Biopol Chemicals Ltd?

Biopol Chemicals Ltd Debt to cash flow from operations is -3.29, which is at a unhealthy level.

Q: Revenue growth of Biopol Chemicals Ltd vs industry peers?

Biopol Chemicals Ltd revenue CAGR is %, compared to the industry median CAGR of 24.05%, indicating slower growth and losing its market share. Profit Metrics. Revenue Growth (%), Current: -, Industry Median: 24.1. Gross Profit Growth (%), Current: 200, Industry Median: 39.5. Operating Profit Growth (%), Current: 250, Industry Median: 42.8. Net Profit Growth (%), Current: 300, Industry Median: 44.2. Operating Efficiency. Asset Turnover (x), Current: 2.01, Historic Median: 1.18. ROE (%), Current: -, Historic Median: 14.12. ROCE (%), Current: -, Historic Median: 17.12. Cash Conversion Cycle (days), Current: 116.02, Historic Median: 85

Q: Stock return of Biopol Chemicals Ltd over the last decade?

Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price. Share Price CAGR. 9Y: -. 5Y: -. 3Y: -. 1Y: -

Q: Valuation ratios of Biopol Chemicals Ltd vs historical?

The current P/E ratio of 14.63 is lower than its historical median of 20.55, indicating that the stock is trading below its historical average valuation.

Check Before You Invest : Biopol Chemicals Ltd

Snapshot

Q.1 Which industry/sub-sector does Biopol Chemicals Ltd belong to?

Biopol Chemicals Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.

Q.2 Is Biopol Chemicals Ltd a good quality company?

Biopol Chemicals Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

Q.3 Is Biopol Chemicals Ltd undervalued or overvalued?

Biopol Chemicals Ltd appears Undervalued, as its key valuation ratios are lower than their past averages.

Based on the industry it operates in, the relevant valuation ratios include one of the following, P/E, P/BV, P/Sales, EV/EBITDA or a combination of two or more.

Valuation Ratios	Current	0-year Historic Median
Price to Earnings	14.63	20.55
Price to Book	2.63	2.04
Price to Sales	1.62	1.57
EV to EBITDA	10.08	14.58

Q.4 Is Biopol Chemicals Ltd a good buy now?

Biopol Chemicals Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

C: How much debt does the business have and is it at a sustainable level?

Q.1 Debt to Equity ratio of Biopol Chemicals Ltd?

Biopol Chemicals Ltd Debt-to-Equity ratio is 0.57, which is above the industry average of , indicating higher debt levels in the industry.

Q.2 Debt to cash flow from operations of Biopol Chemicals Ltd?

Biopol Chemicals Ltd Debt to cash flow from operations is -3.29, which is at a unhealthy level.

Ownership & governance

D: Promoter shareholding and pledge status of Biopol Chemicals Ltd?

Q.1 Promoter shareholding and pledge status of Biopol Chemicals Ltd?

Promoters hold 65.81% of the Biopol Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

E: How does Biopol Chemicals Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Biopol Chemicals Ltd vs industry peers?

Biopol Chemicals Ltd revenue CAGR is %, compared to the industry median CAGR of 24.05%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	0-year Industry Median
Revenue Growth (%)	-	24.1
Gross Profit Growth (%)	200	39.5
Operating Profit Growth (%)	250	42.8
Net Profit Growth (%)	300	44.2

Operating Efficiency

	Current Level	0-year Industry Median
Asset Turnover (x)	2.01	1.18
ROE (%)	-	14.12
ROCE (%)	-	17.12
Cash Conversion Cycle (days)	116.02	85

Valuation & price assessment

Q.1 Stock return of Biopol Chemicals Ltd over the last decade?

Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

	9Y	5Y	3Y	1Y
Share Price CAGR	-	-	-	-

Q.2 Valuation ratios of Biopol Chemicals Ltd vs historical?

The current P/E ratio of 14.63 is lower than its historical median of 20.55, indicating that the stock is trading below its historical average valuation.

Q.3 How do the current valuation ratios compare with 0-year historical median and industry numbers?

Valuation Ratios	Current	0-year Historic Median	0-year Industry Median
Price to Earnings	14.63	20.55	-
Price to Book	2.63	2.04	-
Price to Sales	1.62	1.57	-
EV to EBITDA	10.08	14.58	-

Check more companies

1. Navin Fluorine Intl

2. Godrej Industries

3. Deepak Nitrite

4. Atul

5. Tata Chemicals

6. Deepak Fert & Petro

7. Aarti Inds

8. Anupam Rasayan India

9. Aether Industries

10. BASF India

Check trending companies

1. Granules India Ltd.

2. Nestle India Ltd.

3. National Aluminium Company Ltd.

4. Muthoot Finance Ltd.

5. Motilal Oswal Financial Services Ltd.

Check Before You Invest : Biopol Chemicals Ltd

Snapshot

Performance Analysis

Ownership & governance

Peer comparison (industry-wise, mcap)

Profit Metrics

Operating Efficiency

Valuation & price assessment

Check more companies

Check trending companies

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.